Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition

Hidalgo-Mazzei, Diego, Berk, Michael, Cipriani, Andrea, Cleare, Anthony J., Di Florio, Arianna ORCID:, Dietch, Daniel, Geddes, John, Goodwin, Guy M., Grunze, Heinz, Hayes, Joseph F, Jones, Ian ORCID:, Kasper, Siegfried, Macritchie, Karine, McAllister-Williams, R. Hamish, Morriss, Richard, Nayrouz, Sam, Pappa, Sofia, Soares, Jair C., Smith, Daniel J., Suppes, Trisha, Talbot, Peter S., Vieta, Eduard, Watson, Stuart, Yatham, Lakshmi N., Young, Allan H. and Stokes, Paul R.A. 2018. Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition. British Journal of Psychiatry 10.1192/bjp.2018.257

[thumbnail of Manuscriptrevised_09_10_2018_PRS_clean.pdf]
PDF - Accepted Post-Print Version
Download (288kB) | Preview


Background Most people with bipolar disorder spend a significant percentage of their lifetime experiencing either subsyndromal depressive symptoms or major depressive episodes, which contribute greatly to the high levels of disability and mortality associated with the disorder. Despite the importance of bipolar depression, there are only a small number of recognised treatment options available. Consecutive treatment failures can quickly exhaust these options leading to treatment-resistant bipolar depression (TRBD). Remarkably few studies have evaluated TRBD and those available lack a comprehensive definition of multi-therapy-resistant bipolar depression (MTRBD). Aims To reach consensus regarding threshold definitions criteria for TRBD and MTRBD. Method Based on the evidence of standard treatments available in the latest bipolar disorder treatment guidelines, TRBD and MTRBD criteria were agreed by a representative panel of bipolar disorder experts using a modified Delphi method. Results TRBD criteria in bipolar depression was defined as failure to reach sustained symptomatic remission for 8 consecutive weeks after two different treatment trials, at adequate therapeutic doses, with at least two recommended monotherapy treatments or at least one monotherapy treatment and another combination treatment. MTRBD included the same initial definition as TRBD, with the addition of failure of at least one trial with an antidepressant, a psychological treatment and a course of electroconvulsive therapy. Conclusions The proposed TRBD and MTRBD criteria may provide an important signpost to help clinicians, researchers and stakeholders in judging how and when to consider new non-standard treatments. However, some challenging diagnostic and therapeutic issues were identified in the consensus process that need further evaluation and research.

Item Type: Article
Date Type: Published Online
Status: Published
Schools: Medicine
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher: Cambridge University Press
ISSN: 0007-1250
Date of First Compliant Deposit: 16 November 2018
Date of Acceptance: 24 October 2018
Last Modified: 07 Nov 2023 02:41

Citation Data

Cited 37 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics